Results 251 to 260 of about 1,521,979 (308)

Driving with Motor Neuron Disease: Disease-Specific Considerations, Multi-Domain Assessments and Support Strategies. [PDF]

Brain Sci
Kleinerova J, Tully J, Lope J, Tan EL, Toomey A, Siah WF, Bede P.   +6 more
europepmc   +1 more source

Impact of a Personalized, High-Dose, Intensive Motor Rehabilitation Program, Integrating Advanced Technology for Adults With Central Neurological Conditions (INTeRAcT): Protocol for a Single-Blind Randomized Controlled Trial With a Clinical, Health Economic, and Process Evaluation. [PDF]

JMIR Res Protoc
Coremans M, Allewijn I, Bataillie F, De Bruyn L, Fobelets M, Jacobs F, Janssens S, Pattyn L, Putman K, Schiltz A, Tedesco Triccas L, Van Thienen F, Verheyden G.   +12 more
europepmc   +1 more source

Increased Risk of Injury in Patients with Fabry Disease: A Nationwide Population-Based Cohort Study in Taiwan. [PDF]

Int J Med Sci
Cheng CG, Chen YH, Chien WC, Chiu HW, Hung FH, Peng HP, Chung CH, Cheng CA.   +7 more
europepmc   +1 more source

Potential for use of Al/machine learning for pharmacovigilance: Is there a role for regulators?

British Journal of Clinical Pharmacology, EarlyView.
Christina Gao, Ashley M. Hopkins, Andrew Rowland, Stephen Bacchi   +3 more
wiley   +1 more source

Individualised stimlation parameters in deep brain stimulation for Parkinson's disease based on disease phenotype and brain connectivity: protocol for a randomised feasibility study in a tertiary care centre (iDBS trial). [PDF]

BMJ Open
de Ronde EM, Birnie E, Rijpma A, Arnts H, Bartels RHMA, Esselink R, Vinke RS.   +6 more
europepmc   +1 more source

Protocol of the interdisciplinary and intersectoral randomized controlled trial in Parkinson patients in a specialized network in Germany: the INSPIRE Trial. [PDF]

Neurol Res Pract
Schneider SA, Paryjas S, Beyer F, Bach JP, Baudrexel S, Baier B, Ajia MA, Csoti I, Gehring K, Escamilla GG, Herz DM, Leisse M, Köhler L, Krause TM, Martens D, Meier U, Scheipers M, Schiffer J, Schröter N, Schulz R, Specht S, Erbsland M, Stemmer R, Groppa S.   +23 more
europepmc   +1 more source

Health economic considerations for pharmacogenomic services in the United Kingdom: The Centre for Excellence in Regulatory Science and Innovation in Pharmacogenomics

British Journal of Clinical Pharmacology, EarlyView.
Dyfrig A. Hughes, Henry Fong, Grace Hampson, Catrin O. Plumpton, Chris Sampson   +4 more
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Models in Motor Insurance.

Journal of the Staple Inn Actuarial Society, 1978
The introduction of high-speed electronic computers has opened the way for analyses of motor insurance risk statistics on a scale not previously possible. We may regard the purpose of the analyses which form the subject of this note as being to test the validity of the existing rating structure by finding out how the claims experience varies from one ...
openaire   +1 more source

Green Motor Insurance

European Energy and Environmental Law Review, 2014
Several Studies indicate ecodriving as a strategy to reduce greenhouse gas (GHG) emissions. The word ecodriving commonly indicates the combination of some driving techniques and style of driving. Insurers can represent an instrument to improve ecodriving.
openaire   +2 more sources